| Literature DB >> 26830967 |
Xinping Fan1,2, Johanna A Kremer Hovinga3, Hiroko Shirotani-Ikejima1, Yuka Eura1, Hidenori Hirai1, Shigenori Honda1, Koichi Kokame1, Magnus Mansouri Taleghani4, Anne-Sophie von Krogh5,6, Yoko Yoshida7, Yoshihiro Fujimura7, Bernhard Lämmle4,8, Toshiyuki Miyata9,10.
Abstract
The congenital form of thrombotic thrombocytopenic purpura (TTP) is caused by genetic mutations in ADAMTS13. Some, but not all, congenital TTP patients manifest renal insufficiency in addition to microangiopathic hemolysis and thrombocytopenia. We included 32 congenital TTP patients in the present study, which was designed to assess whether congenital TTP patients with renal insufficiency have predisposing mutations in complement regulatory genes, as found in many patients with atypical hemolytic uremic syndrome (aHUS). In 13 patients with severe renal insufficiency, six candidate complement or complement regulatory genes were sequenced and 11 missense mutations were identified. One of these missense mutations, C3:p.K155Q mutation, is a rare mutation located in the macroglobulin-like 2 domain of C3, where other mutations predisposing for aHUS cluster. Several of the common missense mutations identified in our study have been reported to increase disease-risk for aHUS, but were not more common in patients with as compared to those without renal insufficiency. Taken together, our results show that the majority of the congenital TTP patients with renal insufficiency studied do not carry rare genetic mutations in complement or complement regulatory genes.Entities:
Keywords: Atypical hemolytic uremic syndrome; Complement factors; Renal insufficiency; Thrombotic thrombocytopenic purpura; Upshaw–Schulman syndrome
Mesh:
Substances:
Year: 2016 PMID: 26830967 DOI: 10.1007/s12185-015-1933-7
Source DB: PubMed Journal: Int J Hematol ISSN: 0925-5710 Impact factor: 2.490